Salivary Inflammatory Markers in Trichotillomania: A Pilot Study. by Grant, Jon E & Chamberlain, Samuel
Original Article
Neuropsychobiology 2017;76:182–186
Salivary Inflammatory Markers in 
Trichotillomania: A Pilot Study
Jon E. Grant a    Samuel R. Chamberlain b    
a
 Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA; b Department of 
Psychiatry, University of Cambridge, Cambridge and Peterborough NHS Foundation Trust, Cambridge, UK
Received: March 15, 2018
Accepted after revision: May 6, 2018
Published online: June 19, 2018
Jon E. Grant, JD, MD, MPH
Department of Psychiatry and Behavioral Neuroscience, University of Chicago
Pritzker School of Medicine, 5841 S. Maryland Avenue, MC 3077
Chicago, IL 60637 (USA)
E-Mail jongrant @ uchicago.edu
© 2018 The Author(s)
Published by S. Karger AG, Basel
E-Mail karger@karger.com
www.karger.com/nps
DOI: 10.1159/000489865
Keywords
Trichotillomania · Inflammation · Interleukin-6 · 
Interleukin-8 · Interleukin-1beta · Tumor necrosis  
factor-alpha · Cytokines
Abstract
Background: Immune dysregulation has been hypothesized 
to be important in the development and pathophysiology of 
compulsive disorders such as obsessive compulsive disorder 
(OCD), which has a high comorbid overlap with trichotillo-
mania (both are OC-related disorders). The role of inflamma-
tion in the pathophysiology of trichotillomania has garnered 
little research to date. Methods: Individuals with trichotillo-
mania provided saliva sample for analysis of inflammatory 
cytokines. Additionally, these participants were examined 
on a variety of demographic variables (including body mass 
index [BMI], previously found to relate to inflammation) 
along with clinical measures (symptom severity, function-
ing, and comorbidity). Results: Thirty-one participants, 
mean age of 24.7 (±10.2) years, 27 (87.1%) females were 
 included. The mean score on the Massachusetts Gener-
al Hospital Hair Pulling Scale was 15.7 (±4.2), reflective of 
moderate symptom severity. Compared to normative data, 
the mean inflammatory marker levels in the trichotilloma-
nia sample had the following Z scores: interleukin-1β (IL-1β) 
Z = –0.26, IL-6 Z = –0.39, IL-8 Z = –0.32, and tumor necrosis 
factor-α Z = –0.83. Levels of inflammatory markers did not 
correlate significantly with BMI, depressive mood, symptom 
severity, or disability. Conclusions: The relatively low level of 
inflammatory saliva cytokines observed in the current study 
(negative z scores versus normative data with medium effect 
sizes) indicates that evaluation of blood inflammatory levels 
in trichotillomania versus matched controls would be valu-
able in future work. If a hypoinflammatory state is confirmed 
 using blood samples, this would differentiate trichotilloma-
nia from other mental disorders (such as OCD, schizophre-
nia, and depression), which have typically been linked with 
high inflammatory measures in the literature, at least in 
some cases. © 2018 The Author(s) 
Published by S. Karger AG, Basel
Introduction
Trichotillomania is an under-recognized and often-
times functionally impairing condition in which individ-
uals repeatedly pull out their hair [1]. Although described 
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in the medical literature for almost 2 centuries, trichotil-
lomania remains poorly understood with limited data re-
garding its pathophysiology [2]. Trichotillomania consti-
tutes a relatively specific type of behavior, characterized 
in terms of excessive grooming, which also occurs in oth-
er animal species. As such, across psychiatric disorders, 
the biological substrates of trichotillomania may be par-
ticularly well suited to translational modeling [3]. Obses-
sive compulsive disorder (OCD) and trichotillomania are 
both classified as Obsessive-Compulsive Related Disor-
ders in the Diagnostic and Statistical Manual Version 5, 
in recognition of their high comorbidity, phenomenology 
(repetitive habitual behaviors), and possible overlapping 
involvement of dysfunctional fronto-striatal circuitry 
(striatum and frontal cortices) [2, 3]. 
There are several lines of evidence to suggest a role for 
immune-mediated pathophysiology in a variety of psy-
chiatric conditions, including OCD, a disorder with phe-
nomenological and possibly biological links to trichotil-
lomania [4]. Studies measuring plasma cytokine levels 
have demonstrated a significant reduction in interleukin-
1β (IL-1β) levels in OCD subjects compared with con-
trols, but no significant differences in plasma levels of 
IL-6 and tumor necrosis factor-α (TNF-α) have been 
shown [5]. A recent case-control study of 20 adults with 
OCD who underwent PET imaging, however, found that 
translocator protein distribution volume (translocator 
protein density increases when microglia are activated 
during neuroinflammation and the distribution volume 
is an index of translocator protein density) was signifi-
cantly elevated in the dorsal caudate, orbitofrontal cortex, 
thalamus, ventral striatum, and dorsal putamen [6] dem-
onstrating inflammation within the neurocircuitry of 
OCD. The only study which included subjects with 
trichotillomania examined cerebrospinal fluid and found 
that the mean cerebrospinal fluid IL-6 levels did not differ 
between OCD patients (n = 26) and controls or between 
trichotillomania patients (n = 9) and their matched con-
trols [7]. 
Cytokines are small, soluble proteins secreted by cells 
to influence the behavior of other cells via regulation of 
cellular immunity and inflammatory response. Pro-in-
flammatory cytokines include IL-1β, IL-6, and TNF-α, 
which are produced both peripherally and in the central 
nervous system. TNF-α stimulates vagal afferents and is 
produced by neurons and glial cells in an activity-depen-
dent manner [8, 9]. IL-6 and IL-1 are also produced in the 
brain, where they mediate neuroinflammation and re-
sponse to injury [9, 10]. Interestingly, IL-1β, IL-6, and 
TNF-α also mediate neuroprotection to excitotoxicity 
[11]. IL-8 is associated with inflammation and is in-
creased by oxidant stress, which in a vicious cycle causes 
the recruitment of inflammatory cells and induces an in-
crease in oxidant stress mediators. While poorly under-
stood, it is increasingly recognized that there is important 
cross-talk between the peripheral immune system and 
central nervous system functioning, whereby inflamma-
tion may influence psychiatric symptoms and cognition 
[12, 13]. 
Although some studies shed some light on the topic of 
possible role inflammation in compulsive disorders, 
many questions remain unanswered. Understanding the 
role of cytokines in compulsive behaviors such as tricho-
tillomania may allow for a greater understanding of the 
pathophysiology underlying this disorder and related dis-
orders. Based on the extant literature, we hypothesized 
that salivary cytokine levels would be abnormal in tricho-
tillomania. By examining the relationship between sali-
vary cytokines and trichotillomania, we hope to deter-
mine a possible biological signal supportive of follow-up 
work using blood samples (which may more accurately 
capture central inflammatory pathways than saliva). 
Methods
Ethical Approval
Study procedures were carried out in accordance with the Dec-
laration of Helsinki. The Institutional Review Board at the Univer-
sity of Chicago approved the study and subjects provided written 
informed consent. In the case of non-adults, parental consent was 
obtained. 
Subjects
Data from 31 female participants with primary trichotilloma-
nia were included in this study. All subjects had a current Diagnos-
tic and Statistical Manual Version 5 primary diagnosis of trichotil-
lomania (American Psychiatric Association, 2013). Other inclu-
sion criteria included age 10–66 years, the ability to be interviewed 
in person, and willingness to provide a saliva sample. Exclusion 
criteria included prior/current diagnosis of bipolar disorder or 
psychosis or current substance use disorder.
Assessments
Individuals with a primary diagnosis of trichotillomania were 
examined using a semi-structured interview focusing on the clini-
cal features of trichotillomania. Each participant (or their parent 
in the case of non-adults) provided their history of psychiatric dis-
orders. 
Body mass index (BMI) was calculated for each participant us-
ing the standard formula BMI = w/h squared, where w is the weight 
in kilograms and h is the height in meters. For the present analyses, 
obesity was defined as a BMI greater than 30 kg/m2, overweight as 
a BMI less than 30 kg/m2, but greater than or equal to 25 kg/m2, 
and normal weight as a BMI greater than 18.5 kg/m2 but less than 
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25 kg/m2. We recorded BMI because previous studies have found 
strong relationships between elevated BMI and inflammation in 
the context of depression and healthy controls [14]. 
Participants also provided a saliva sample via passive drool. 
Participants were not allowed to eat, drink, smoke, or use any oral 
hygiene products for at least 1 h before the saliva collection. Saliva 
levels of IL-1β, IL-6, IL-8, and TNF-α were quantified (for assay 
methodology, see www.salimetrics.com). We opted for saliva sam-
ples because they are minimally invasive and convenient, com-
pared to blood tests. While saliva samples have relatively weak cor-
relations with blood levels of cytokines (the strongest evidence is 
for a significant albeit relatively small correlation with IL-6) [15, 
16], we believed that an initial pilot study using saliva would con-
stitute a valuable research step; since significant associations be-
tween saliva inflammatory markers and trichotillomania would 
support future work using blood tests. 
Severity of trichotillomania, depressive symptoms, psychoso-
cial dysfunction, and impulsivity were assessed using the following 
measures:
The Massachusetts General Hospital Hair Pulling Scale (MGH-
HPS) [17, 18]. The MGH-HPS is a valid and reliable 7-item, self-
report scale that rates urges to pull hair, actual amount of pulling, 
perceived control over behavior, and distress associated with hair 
pulling over the preceding 7 days. 
Mood and Feelings Questionnaire. Mood and Feelings Ques-
tionnaire 13-item adult short version, is a well validated instru-
ment consisting of a series of descriptive phrases regarding how 
the subject has been feeling or acting most of the time, sometimes, 
or not at all during the previous 2 weeks [19].
Sheehan Disability Scale (SDS) [20]. The SDS is a valid and re-
liable scale that evaluates psychosocial dysfunction in 3 domains: 
work/school, social life, and home/family life. 
Barratt Impulsiveness Scale, Version 11. The Barratt Impul-
siveness Scale, Version 11 is a 30-item measure designed to assess 
impulsivity across 3 dimensions: attentional (inability to concen-
trate), motor (acting without thinking), and non-planning (lack of 
future orientation) [21]. 
Data Analysis
Demographic, clinical, and salivary cytokine level data were 
presented in summary form. Relationships between demographic/
clinical measures (age, education level, MGH-HPS, SDS total 
scores) and salivary cytokine (IL-1β, IL-6, IL-8, and TNF-α) were 
explored using correlation tests (Spearman’s r; or Wilcoxon’s z for 
gender comparisons). Statistical significance was defined as p  < 
0.05 2-tailed. We did not adjust the alpha level to reflect all statisti-
cal comparisons because this is one of the first studies of this topic 
and is therefore exploratory.
Results
The sample comprised 31 individuals with trichotillo-
mania (mean age of 24.7 ± SD 10.2 years), of whom most 
(27 [87.1%] were females. The mean total score on the 
MGH-HPS was 15.7 [± SD 4.2]), reflective of moderate 
trichotillomania symptom severity. Of the 31 partici-
pants, 10 (32.2%) had co-occurring skin picking disorder, 
but in each case, the trichotillomania was self-reported as 
their primary difficulty based on interference in their 
lives. Four (12.9%) had lifetime histories of major depres-
sive disorder, with 9 (29.0%) taking antidepressants. Par-
ticipants did not report any ongoing health issues and 
were not taking any other medications or supplements on 
a regular basis, other than 2 participants who reported 
occasional (i.e., less than 1 time per week) use of NSAIDS.
Saliva testing showed the following levels (all expressed 
in pg/mL): IL-1β (86.4 ± 103.2), IL-6 (3.6 ± 3.1), IL-8 
(638.7 ± 622.7), and TNF-α (2.54 ± 1.98). Compared to 
normative data [16, 22], the mean inflammatory marker 
levels in the trichotillomania sample had the following Z 
scores: IL-1β Z = –0.26, IL-6 Z = –0.39, IL-8 Z = –0.32, 
and TNF-α Z = –0.83. 
Salivary inflammatory levels correlated significantly 
with age (IL-1β r = 0.433, p = 0.015; IL-6 r = 0.361, p = 
0.046; IL-8 r  = 0.437, p  = 0.014; TNF-α r  = 0.375, p  = 
0.038). Inflammatory levels did not differ as a function of 
gender (IL-1β Wilcoxon Z = –0.56, p = 0.586; IL-6 Z = 
1.03, p = 0.302; IL-8 Z < 0.01, p > 0.99; TNF-α Z = 0.147, 
p = 0.883). Inflammatory measures did not correlate with 
trichotillomania symptom severity (IL-1β r = –0.163, p = 
0.407; IL-6 r < 0.01, p > 0.99; IL-8 r = 0.153, p = 0.558; 
TNF-α r = 0.080, p = 0.686), or with Sheehan disability 
(IL-1β r = –0.154, p = 0.433; IL-6 r < 0.01, p > 0.99; IL-8 
r < 0.001, p > 0.99; TNF-α r = –0.061, p = 0.757), or Bar-
ratt scores (IL-1β r = –0.089, p = 0.735; IL-6 r = 0.325, p = 
0.204; IL-8 r  = 0.153, p  = 0.558; TNF-α r  = 0.130, p  = 
0.620), or BMI (IL-1β r = 0.309, p = 0.173; IL-6 r = 0.325, 
p = 0.204; IL-8 r = 0.153, p = 0.558; TNF-α r = 0.239, p = 
0.300), or depressed mood (IL-1β r = 0.110, p = 0.655; 
IL-6 r = 0.319, p = 0.184; IL-8 r = 0.299, p = 0.214; TNF-α 
r = 0.063, p = 0.800). There were no differences between 
those participants taking or not taking an antidepressant.
Discussion
Inflammatory dysfunction has been implicated in oth-
er mental health disorders such as OCD and schizophre-
nia [4, 12], but has received scant study in the context of 
trichotillomania. The current study examined a range of 
salivary inflammatory markers (IL-1β, IL-6, IL-8, and 
TNF-α) in a sample of patients with trichotillomania, and 
whether inflammation related to symptom severity and 
other clinical measures. The key finding was that patients 
overall had relatively low level of salivary inflammatory 
markers compared to externally published norms. Re-
duced autonomic response to painful stimulation, mea-
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sured using the cold pressor task, has previously been re-
ported in trichotillomania [23] and in skin picking disor-
der [24]. Many patients with trichotillomania report that 
hair pulling is not painful, especially after the habit has 
developed [25]. In the general population, cold pressor 
task pain perception was positively correlated with high-
er inflammation as indexed by C-reactive protein [26]. 
Acute inflammation in healthy volunteers, such as in-
duced by an endotoxin model, increases pain response on 
the Cold Pressor test [27]. Therefore, 1 intriguing possi-
bility raised by the present data is that inflammatory 
pathways are dampened in trichotillomania; and that this 
in turn may contribute to persistence of hair pulling due 
to reduced pain response. However, confirmation of this 
would require follow-up work using blood samples, 
which are more directly related to systemic inflammatory 
pathways, than saliva samples. In a prior meta-analysis, a 
significant reduction in IL-1β levels was found in OCD 
subjects compared with controls, but no significant dif-
ferences in plasma levels of IL-6 and TNF-α were ob-
served [5]. Thus, the current findings may indicate com-
mon reduction of IL-1β across OCD and trichotilloma-
nia, but that trichotillomania is linked with a broader 
range of inflammatory changes. 
Several limitations need to be considered in relation to 
the current study. The study did not include a control 
group, and so analyses were correlational in nature, and 
used external published norms as a reference. We did not 
record the duration of illness. As noted, we used saliva 
samples, which may only weakly reflect central inflam-
matory pathways. This being an exploratory study, we did 
not correct for multiple comparisons. 
In summary, relatively low level of salivary inflamma-
tory cytokines were observed in people with trichotillo-
mania. Follow-up work is now needed to examine inflam-
mation using blood measures in people with this condi-
tion, ideally also including a normative control group 
(not included in the current design). If blood measures 
show the same pattern of results as seen here with saliva, 
trichotillomania may be distinct from other mental dis-
orders (such as OCD, schizophrenia, and depression), 
which have been associated tentatively with increased 
rather than decreased peripheral inflammation [4]. In-
flammatory findings in mental disorders, however, are 
highly heterogeneous and may reflect distinct subtypes. 
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